{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T19:33:47Z","timestamp":1789414427069,"version":"build-2803163510"},"reference-count":19,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Colorectal cancer liver metastases (CRLM) are a common manifestation of colorectal cancer, and clinical decision-making for these patients is complex. The timing of CRLM detection, defined as synchronous, early metachronous, or late metachronous, is hypothesized to influence survival outcomes, but the prognostic implications of these classifications remain unclear.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To determine whether the timing of CRLM detection is associated with overall survival (OS) in patients with up-front locally treatable or initially nonlocally treatable CRLM.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n Multicenter cohort study including adult patients from the Amsterdam Colorectal Liver Met Registry and the phase 3 CAIRO5 trial between 2000 and 2024, with analyses conducted from March 2025 to January 2026. Patients were followed up for a median (IQR) of 44 (41-48) months. Survival outcomes were analyzed using multivariable Cox regression models. Inclusion criteria were up-front locally treatable or initially nonlocally treatable CRLM, with key clinical and demographic characteristics recorded.<\/jats:p>\n <\/jats:sec>\n \n Exposure<\/jats:title>\n Timing of CRLM detection categorized as synchronous (detected before or at primary CRC diagnosis or during surgery), early metachronous (within 12 months of diagnosis or surgery), or late metachronous (more than 12 months after surgery), according to European-African Hepato-Pancreato-Biliary Association consensus guidelines.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n OS from diagnosis of CRLM, stratified by CRLM timing and treatment received. Multivariable analysis accounted for tumor number, size, variant status, carcinoembryonic antigen levels, and treatment strategy.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n A total of 1250 patients were included (median [IQR] age, 63 [56-72] years; 823 [65.9%] men), of whom 817 (65%) had synchronous CRLM, 208 (17%) early metachronous CRLM, and 225 (18%) late metachronous CRLM. Among all patients, 676 (54%) died during follow-up. Synchronous CRLM were associated with worse OS compared with early metachronous CRLM (hazard ratio [HR], 0.79; 95% CI, 0.64-0.97) and late metachronous CRLM (HR, 0.54; 95% CI, 0.43-0.68). After adjustment for tumor and treatment factors, timing of detection of CRLM was not independently associated with OS.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this retrospective multicenter cohort study, timing of CRLM detection was not associated with OS when accounting for tumor characteristics and treatment strategy. These findings suggest that synchronicity may primarily reflect underlying tumor biology rather than directly influencing survival, emphasizing that clinical decisions should focus on synchronicity in combination with tumor burden, variant status, and local treatment.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.2088","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T15:00:27Z","timestamp":1773759627000},"page":"e262088","source":"Crossref","is-referenced-by-count":2,"title":["Time of Detection of Liver Metastases and Survival in Patients With Colorectal Cancer"],"prefix":"10.1001","volume":"9","author":[{"given":"Ruby","family":"Kemna","sequence":"first","affiliation":[{"name":"Amsterdam University Medical Center, Department of Surgery, VU University, Amsterdam, the Netherlands"},{"name":"Cancer Center Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah H.","family":"Schulz","sequence":"additional","affiliation":[{"name":"Cancer Center Amsterdam, the Netherlands"},{"name":"Amsterdam UMC, Department of Radiology and Nuclear Medicine, VU University, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsoem","family":"Ali","sequence":"additional","affiliation":[{"name":"Amsterdam University Medical Center, Department of Surgery, VU University, Amsterdam, the Netherlands"},{"name":"Cancer Center Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madelon","family":"Dijkstra","sequence":"additional","affiliation":[{"name":"Cancer Center Amsterdam, the Netherlands"},{"name":"Amsterdam UMC, Department of Radiology and Nuclear Medicine, VU University, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"van der Lei","sequence":"additional","affiliation":[{"name":"Cancer Center Amsterdam, the Netherlands"},{"name":"Amsterdam UMC, Department of Radiology and Nuclear Medicine, VU University, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinde J. G.","family":"Bond","sequence":"additional","affiliation":[{"name":"University Medical Centre Utrecht, Department of Epidemiology, Julius Centre for Health Sciences and Primary Care, Utrecht University, Utrecht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis J. A.","family":"Punt","sequence":"additional","affiliation":[{"name":"University Medical Centre Utrecht, Department of Epidemiology, Julius Centre for Health Sciences and Primary Care, Utrecht University, Utrecht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inez M.","family":"Verpalen","sequence":"additional","affiliation":[{"name":"Cancer Center Amsterdam, the Netherlands"},{"name":"Amsterdam UMC, Department of Radiology and Nuclear Medicine, VU University, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tineke E.","family":"Buffart","sequence":"additional","affiliation":[{"name":"Cancer Center Amsterdam, the Netherlands"},{"name":"Amsterdam UMC, Department of Medical Oncology, VU University, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutger-Jan","family":"Swijnenburg","sequence":"additional","affiliation":[{"name":"Amsterdam University Medical Center, Department of Surgery, VU University, Amsterdam, the Netherlands"},{"name":"Cancer Center Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"Kazemier","sequence":"additional","affiliation":[{"name":"Amsterdam University Medical Center, Department of Surgery, VU University, Amsterdam, the Netherlands"},{"name":"Cancer Center Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn R.","family":"Meijerink","sequence":"additional","affiliation":[{"name":"Cancer Center Amsterdam, the Netherlands"},{"name":"Amsterdam UMC, Department of Radiology and Nuclear Medicine, VU University, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"issue":"2","key":"zoi260093r1","doi-asserted-by":"publisher","first-page":"150","DOI":"10.4254\/wjh.v11.i2.150","article-title":"Colorectal liver metastases: an update on multidisciplinary approach.","volume":"11","author":"Chow","year":"2019","journal-title":"World J Hepatol"},{"issue":"8","key":"zoi260093r2","doi-asserted-by":"publisher","first-page":"838","DOI":"10.6004\/jnccn.2009.0057","article-title":"NCCN clinical practice guidelines in oncology: rectal cancer.","volume":"7","author":"Engstrom","year":"2009","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"zoi260093r3","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12957-019-1771-9","article-title":"Synchronous and metachronous liver metastases in patients with colorectal cancer-towards a clinically relevant definition.","volume":"17","author":"Engstrand","year":"2019","journal-title":"World J Surg Oncol"},{"issue":"9","key":"zoi260093r4","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.ctrv.2015.06.006","article-title":"Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus.","volume":"41","author":"Adam","year":"2015","journal-title":"Cancer Treat Rev"},{"issue":"9","key":"zoi260093r5","doi-asserted-by":"publisher","first-page":"719","DOI":"10.47102\/annals-acadmedsg.V39N9p719","article-title":"Colorectal cancer liver metastases - understanding the differences in the management of synchronous and metachronous disease.","volume":"39","author":"Tan","year":"2010","journal-title":"Ann Acad Med Singap"},{"key":"zoi260093r6","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5353727","article-title":"Analysis of prognostic factors for resected synchronous and metachronous liver metastases from colorectal cancer.","volume":"2018","author":"Bartolini","year":"2018","journal-title":"Gastroenterol Res Pract"},{"key":"zoi260093r7","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.jss.2020.06.038","article-title":"Synchronous versus metachronous colorectal liver metastasis yields similar survival in modern era.","volume":"256","author":"Wisneski","year":"2020","journal-title":"J Surg Res"},{"issue":"8","key":"zoi260093r8","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1007\/s11605-008-0508-9","article-title":"Survival of patients with synchronous and metachronous colorectal liver metastases\u2013is there a difference?","volume":"12","author":"Bockhorn","year":"2008","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"zoi260093r9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/ags3.12227","article-title":"Multidisciplinary approach of liver metastases from colorectal cancer.","volume":"3","author":"Adam","year":"2019","journal-title":"Ann Gastroenterol Surg"},{"issue":"6","key":"zoi260093r10","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/bjs.9449","article-title":"Systematic review of surgical management of synchronous colorectal liver metastases.","volume":"101","author":"Lykoudis","year":"2014","journal-title":"Br J Surg"},{"issue":"4","key":"zoi260093r11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/bjs\/znab457","article-title":"Synchronous resection of primary colorectal cancer with liver metastases: two birds with one stone?","volume":"109","author":"Siriwardena","year":"2022","journal-title":"Br J Surg"},{"issue":"9","key":"zoi260093r12","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1093\/bjs\/znad124","article-title":"Multisocietal European consensus on the terminology, diagnosis, and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE.","volume":"110","author":"Siriwardena","year":"2023","journal-title":"Br J Surg"},{"issue":"4","key":"zoi260093r13","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"zoi260093r14","doi-asserted-by":"publisher","first-page":"b5087","DOI":"10.1136\/bmj.b5087","article-title":"Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes.","volume":"340","author":"L\u00e9vesque","year":"2010","journal-title":"BMJ"},{"issue":"1","key":"zoi260093r15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","article-title":"Metastatic colorectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up.","volume":"34","author":"Cervantes","year":"2023","journal-title":"Ann Oncol"},{"issue":"1","key":"zoi260093r16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/00000658-200001000-00009","article-title":"Indicators for treatment strategies of colorectal liver metastases.","volume":"231","author":"Ueno","year":"2000","journal-title":"Ann Surg"},{"issue":"2","key":"zoi260093r17","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1245\/s10434-006-9215-5","article-title":"Clinicopathological features and prognosis in resectable synchronous and metachronous colorectal liver metastasis.","volume":"14","author":"Tsai","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"zoi260093r18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2025.115738","article-title":"Total tumor volume predicts overall survival and response to induction chemotherapy in patients with colorectal cancer liver metastases: An ancillary study of the phase 3 CAIRO5 trial.","volume":"228","author":"Michiel Zeeuw","year":"2025","journal-title":"Eur J Cancer"},{"key":"zoi260093r19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.106081","article-title":"Combining cell-free DNA fragmentomes and total tumour volume improves prognostication and tumour response evaluation in patients with colorectal cancer liver metastases.","volume":"123","author":"Crnovrsanin","year":"2026","journal-title":"EBioMedicine"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2846559\/kemna_2026_oi_260093_1773168013.11622.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T15:00:27Z","timestamp":1773759627000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2846559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.2088","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]}}}